Literature DB >> 26382011

Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence.

Jufeng Sun1, Suwen Wang2, Hongjuan Li1, Wenguo Jiang1, Guige Hou1, Feng Zhao1, Wei Cong1.   

Abstract

Novel N-aroyl-α,β-unsaturated piperidones, series 1, series 2 and series 3 (featuring 2-bromo-4,5-dimethoxybenzylidene, 4-dimethylaminobenzylidene and 4-trifluoromethylbenzylidene, respectively), were synthesized as candidate cytotoxins. Most of the compounds displayed potent cytotoxicity against the human neoplastic cell lines SK-BR-3, PG-BE1, NCI-H460, MIA PaCa-2 and SW1990 in vitro, and approximately 64% of the IC50 values were lower than 5 μM. Among those tested, compound 1b of series 1, 3a, 3d and 3e of series 3 proved to be the most active. Importantly, 1b displayed marked inhibitory effects on tumor growth in vivo and had no apparent toxicity to mice; this was evaluated by a nude mouse PG-BE1 xenograft model. In addition, the fluorescent properties of compounds series 1-3 were investigated. The interesting fluorescence exhibited by these compounds could be useful for their visualization in tumor cells, permitting further studies on these α,β-unsaturated piperidones as candidates for novel fluorescent antitumor agents.

Entities:  

Keywords:  Antitumor agents; cytotoxicity; fluorescence; xenograft model; α,β-unsaturated piperidones

Mesh:

Substances:

Year:  2015        PMID: 26382011     DOI: 10.3109/14756366.2015.1043296

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  5 in total

1.  Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.

Authors:  Lianshuang Zhang; Qin Chen; Guige Hou; Wei Zhao; Yun Hou
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.

Authors:  Wei Cong; Yue Sun; Yi-Fan Sun; Wei-Bin Yan; Yu-Long Zhang; Zhong-Fei Gao; Chun-Hua Wang; Gui-Ge Hou; Jia-Jing Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

3.  Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells.

Authors:  Rossella Fioravanti; Stefano Tomassi; Elisabetta Di Bello; Annalisa Romanelli; Andrea Maria Plateroti; Rosaria Benedetti; Mariarosaria Conte; Ettore Novellino; Lucia Altucci; Sergio Valente; Antonello Mai
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

4.  In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells.

Authors:  Sze Wei Leong; Suet Lin Chia; Faridah Abas; Khatijah Yusoff
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

5.  Dienone Compounds: Targets and Pharmacological Responses.

Authors:  Martina Bazzaro; Stig Linder
Journal:  J Med Chem       Date:  2020-11-04       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.